# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JMP Securities analyst David Turkaly reiterates Apyx Medical (NASDAQ:APYX) with a Market Perform.
Demonstrates a statistically significant reduction in adverse events associated with the use of Renuvion following liposuction ...
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) ...
Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary heli...
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.21...